Relationship between D-dimer levels and survival in a sample of Iraqi patients with COVID-19

Rusul Adnan Abass; Manal Kamal Rasheed; Ghassan Thabet Saeed Al-Ani

doi:10.53730/ijhs.v8n2.15001

Authors

Rusul Adnan Abass
rusul.a@uodiyala.edu.iq
University of Diyala, Diyala, Iraq
Manal Kamal Rasheed Baghdad University, Baghdad, Iraq
Ghassan Thabet Saeed Al-Ani Baghdad University, Baghdad, Iraq

Keywords:

COVID-19, D-dimer, relationship, survival

Abstract

Coronavirus disease 2019 was discovered in December 2019, Wuhan, China. It was transmitted globally producing the COVID-19 pandemic. Coagulopathy is one of the most common complications characterized by an increased D-dimer level. Objective: The aim of this study were to assessment the relationship between the levels of D-dimer and other biomarkers with survival in a sample of Iraqi patients with COVID-19. Methods: A cross section study included 103 patients affected by COVID-19, diagnosed by PCR and chest CT scan, (18 to 70 years old), and admitted at the isolation centers of the Khalis General Hospital and the Shifa Center in Baquba Teaching Hospital Diyala\ Iraq between November 2020 to end January 2021. The patients were divided into two groups: Group 1:(63) survivors patients, Group 2: (40) non survivors patients. Results: The patients divided into groups: 61.2% survivors patients ,38.8% non-survivors adult COVID-19 patients. The results include several biomarkers, each biomarker (mean± SE) was calculated in survivors and non-survivors patients. Serum ferritin, plasma D-dimer showed statistical significant increasing in non-survivors group (1777.8 ± 126.02, 3985.42 ± 1224.95) than survivors patients group (1182.7 ± 142.45, 1857.50 ± 291.21) with p-value ≥ 0.05.

Downloads

Download data is not yet available.

References

Aditianingsih, D., Soenarto, R. F., Puiantana, A. M., Pranata, R., Lim, M. A., Raharja, P. A. R., ... & Meyer, M. (2022). Dose response relationship between D-Dimer level and mortality in critically ill COVID-19 patients: a retrospective observational study. F1000Research, 11.

Ali, A. M., Rostam, H. M., Fatah, M. H., Noori, C. M., Ali, K. M., & Tawfeeq, H. M. (2022). Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patients. Immunity, inflammation and disease, 10(3), e582.

Becker, R. C. (2020). COVID-19 update: Covid-19-associated coagulopathy. Journal of thrombosis and thrombolysis, 50(1), 54-67.

Chan, K. H., Slim, J., & Shaaban, H. S. (2020). Pulmonary embolism and increased levels of d-dimer in patients with coronavirus disease. Emerging Infectious Diseases, 26(10), 2532-2533.

Cheng, A., Hu, L., Wang, Y., Huang, L., Zhao, L., Zhang, C., ... & Liu, Q. (2020). Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients. International journal of antimicrobial agents, 56(3), 106110. https://doi.org/10.1016/j.ijantimicag.2020.106110

Choi, G. J., Kim, H. M., & Kang, H. (2020). The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews. Journal of Lipid and Atherosclerosis, 9(3), 435.

Choirunisa, C. E., Widhyasih, R. M., & Fajrunni’mah, R. (2023). Correlation of C-Reactive Protein (CRP) Levels with D-Dimer Levels in COVID-19 Patients. Jurnal Ilmu dan Teknologi Kesehatan, 11(1), 126-139.

Demelo-Rodríguez, P., Cervilla-Muñoz, E., Ordieres-Ortega, L., Parra-Virto, A., Toledano-Macías, M., Toledo-Samaniego, N., ... & Galeano-Valle, F. (2020). Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thrombosis research, 192, 23-26. https://doi.org/10.1016/j.thromres.2020.05.018

Dhindsa, S., Zhang, N., McPhaul, M. J., Wu, Z., Ghoshal, A. K., Erlich, E. C., ... & Diwan, A. (2021). Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19. JAMA network open, 4(5), e2111398-e2111398.

Di Gennaro, F., Pizzol, D., Marotta, C., Antunes, M., Racalbuto, V., Veronese, N., & Smith, L. (2020). Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. International journal of environmental research and public health, 17(8), 2690.

Gungor, B., Atici, A., Baycan, O. F., Alici, G., Ozturk, F., Tugrul, S., ... & Barman, H. A. (2021). Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. The American journal of emergency medicine, 39, 173-179. https://doi.org/10.1016/j.ajem.2020.09.018

Han, H., Yang, L., Liu, R., Liu, F., Wu, K. L., Li, J., ... & Zhu, C. L. (2020). Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), 1116-1120.

Huang, I., Pranata, R., Lim, M. A., Oehadian, A., & Alisjahbana, B. (2020). C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Therapeutic advances in respiratory disease, 14, 1753466620937175.

Lim, M. A., Pranata, R., Huang, I., Yonas, E., Soeroto, A. Y., & Supriyadi, R. (2020). Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis. Canadian journal of kidney health and disease, 7, 2054358120938573.

Luo, W. R., Yu, H., Gou, J. Z., Li, X. X., Sun, Y., Li, J. X., ... & Liu, L. (2020). Histopathologic findings in the explant lungs of a patient with COVID-19 treated with bilateral orthotopic lung transplant. Transplantation, 104(11), e329-e331.

Mcgonagle, D. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company‘s public news and information.

Naymagon, L., Zubizarreta, N., Feld, J., van Gerwen, M., Alsen, M., Thibaud, S., ... & Tremblay, D. (2020). Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thrombosis research, 196, 99-105. https://doi.org/10.1016/j.thromres.2020.08.032

Ozen, M., Yilmaz, A., Cakmak, V., Beyoglu, R., Oskay, A., Seyit, M., & Senol, H. (2021). D-Dimer as a potential biomarker for disease severity in COVID-19. The American journal of emergency medicine, 40, 55-59. https://doi.org/10.1016/j.ajem.2020.12.023

Poznyak, A. V., Bezsonov, E. E., Eid, A. H., Popkova, T. V., Nedosugova, L. V., Starodubova, A. V., & Orekhov, A. N. (2021). ACE2 is an adjacent element of atherosclerosis and COVID-19 pathogenesis. International Journal of Molecular Sciences, 22(9), 4691.

Roberts, C. M., Levi, M., McKee, M., Schilling, R., Lim, W. S., & Grocott, M. P. (2020). COVID-19: a complex multisystem disorder. British Journal of Anaesthesia, 125(3), 238-242.

Sakka, M., Connors, J. M., Hékimian, G., Martin-Toutain, I., Crichi, B., Colmegna, I., ... & Frere, C. (2020). Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis. JMV-Journal de Médecine Vasculaire, 45(5), 268-274. https://doi.org/10.1016/j.jdmv.2020.05.003

Santos-Poleo, Y.D., Perez-Sanchez, L., Ocanto, A., Oquillas-Izquierdo, D., & Rodriguez-Recio, F. (2020). Elevated D-dimer and acute pulmonary thromboembolism in patients with COVID-19. Journal of Negative and No Positive Results , 5 (12), 1516-1527.

Schafer, K., Goldschmidt, E., Oostra, D., Fish, J., Russell, T., & Lurie, F. (2022). The clinical significance of ultra-high D-dimer levels. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 8-13. https://doi.org/10.1016/j.jvsv.2021.06.011

Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., ... & Huang, C. (2020). Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology, 5(7), 802-810.

SOGANI, S., PRAJAPAT, R., TOMAR, J., JAIN, S., & BAPNA, A. (2022). STUDY OF D-DIMER AND SERUM FERRITIN LEVELS AS PROGNOSTIC BIOMARKERS IN COVID-19 PATIENTS. Asian J Pharm Clin Res, 15(12), 92-94.

Soni, M., Gopalakrishnan, R., Vaishya, R., & Prabu, P. (2020). D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 2245-2249. https://doi.org/10.1016/j.dsx.2020.11.007

Su, L., Ma, X., Yu, H., Zhang, Z., Bian, P., Han, Y., ... & Gai, Z. (2020). The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID-19. Emerging microbes & infections, 9(1), 707-713.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), 6-9.

Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis, 18(4), 844-847.

Trimaille, A., Thachil, J., Marchandot, B., Curtiaud, A., Leonard-Lorant, I., Carmona, A., ... & Morel, O. (2020). D-dimers level as a possible marker of extravascular fibrinolysis in COVID-19 patients. Journal of Clinical Medicine, 10(1), 39.

Wijayanto, M. A., Myrtha, R., Rahayu, D., & Lukas, G. A. (2023). Can D-dimer predict length of hospital stay in COVID-19 survivors? A cross-sectional study. Jurnal Keperawatan Padjadjaran, 11(2), 112-117.

Wool, G. D., & Miller, J. L. (2021). The impact of COVID-19 disease on platelets and coagulation. Pathobiology, 88(1), 15-27.

Yu, H. H., Qin, C., Chen, M., Wang, W., & Tian, D. S. (2020). D-dimer level is associated with the severity of COVID-19. Thrombosis research, 195, 219-225. https://doi.org/10.1016/j.thromres.2020.07.047

Zhang, L., Yan, X., Fan, Q., Liu, H., Liu, X., Liu, Z., & Zhang, Z. (2020). D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. Journal of thrombosis and haemostasis, 18(6), 1324-1329. https://doi.org/10.1111/jth.14859